Live Attenuated Vaccines Market Report

China Live Attenuated Vaccines Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 25, 2022
  • PAGES：152
  • REPORT CODE：GMM1157211
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or "live"). Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by "killing" the virus (inactivated vaccine).

    Examples of live attenuated) vaccines include: Viral: measles vaccine, mumps vaccine, rubella vaccine and live attenuated influenza vaccine (the seasonal flu nasal spray and the 2009 H1N1 flu nasal spray), etc; Bacterial: BCG vaccine, oral typhoid vaccine and epidemic typhus vaccine.

    This report offers an overview of the market trends, drivers, and barriers with respect to the China Live Attenuated Vaccines market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Live Attenuated Vaccines market. Detailed analysis of key players, along with key growth strategies adopted by Live Attenuated Vaccines industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • CSL

    • Astellas Pharma

    • Sanofi

    • Pfizer

    • Merck

    • GlaxoSmithKline

    • Johnson & Johnson

    • Serum Institute Of India

    By Type:

    • Bacterial

    • Viral

    By End-User:

    • Hospitals

    • Clinics

    • Research Institutes

    • Others

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Live Attenuated Vaccines Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Live Attenuated Vaccines Market Size and Growth Rate of Bacterial from 2016 to 2027

    • 1.3.2 China Live Attenuated Vaccines Market Size and Growth Rate of Viral from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Live Attenuated Vaccines Market Size and Growth Rate of Hospitals from 2016 to 2027

    • 1.4.2 China Live Attenuated Vaccines Market Size and Growth Rate of Clinics from 2016 to 2027

    • 1.4.3 China Live Attenuated Vaccines Market Size and Growth Rate of Research Institutes from 2016 to 2027

    • 1.4.4 China Live Attenuated Vaccines Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Live Attenuated Vaccines Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Live Attenuated Vaccines by Major Types

    • 3.4.1 Market Size and Growth Rate of Bacterial

    • 3.4.2 Market Size and Growth Rate of Viral

    4 Segmentation of Live Attenuated Vaccines Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Live Attenuated Vaccines by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Live Attenuated Vaccines in Hospitals

    • 4.4.2 Market Size and Growth Rate of Live Attenuated Vaccines in Clinics

    • 4.4.3 Market Size and Growth Rate of Live Attenuated Vaccines in Research Institutes

    • 4.4.4 Market Size and Growth Rate of Live Attenuated Vaccines in Others

    5 Market Analysis by Regions

    • 5.1 China Live Attenuated Vaccines Production Analysis by Regions

    • 5.2 China Live Attenuated Vaccines Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Live Attenuated Vaccines Landscape Analysis

    • 6.1 North China Live Attenuated Vaccines Landscape Analysis by Major Types

    • 6.2 North China Live Attenuated Vaccines Landscape Analysis by Major End-Users

    7 Central China Live Attenuated Vaccines Landscape Analysis

    • 7.1 Central China Live Attenuated Vaccines Landscape Analysis by Major Types

    • 7.2 Central China Live Attenuated Vaccines Landscape Analysis by Major End-Users

    8 South China Live Attenuated Vaccines Landscape Analysis

    • 8.1 South China Live Attenuated Vaccines Landscape Analysis by Major Types

    • 8.2 South China Live Attenuated Vaccines Landscape Analysis by Major End-Users

    9 East China Live Attenuated Vaccines Landscape Analysis

    • 9.1 East China Live Attenuated Vaccines Landscape Analysis by Major Types

    • 9.2 East China Live Attenuated Vaccines Landscape Analysis by Major End-Users

    10 Northeast China Live Attenuated Vaccines Landscape Analysis

    • 10.1 Northeast China Live Attenuated Vaccines Landscape Analysis by Major Types

    • 10.2 Northeast China Live Attenuated Vaccines Landscape Analysis by Major End-Users

    11 Southwest China Live Attenuated Vaccines Landscape Analysis

    • 11.1 Southwest China Live Attenuated Vaccines Landscape Analysis by Major Types

    • 11.2 Southwest China Live Attenuated Vaccines Landscape Analysis by Major End-Users

    12 Northwest China Live Attenuated Vaccines Landscape Analysis

    • 12.1 Northwest China Live Attenuated Vaccines Landscape Analysis by Major Types

    • 12.2 Northwest China Live Attenuated Vaccines Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 CSL

      • 13.1.1 CSL Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Astellas Pharma

      • 13.2.1 Astellas Pharma Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Sanofi

      • 13.3.1 Sanofi Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Pfizer

      • 13.4.1 Pfizer Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Merck

      • 13.5.1 Merck Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 GlaxoSmithKline

      • 13.6.1 GlaxoSmithKline Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Johnson & Johnson

      • 13.7.1 Johnson & Johnson Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Serum Institute Of India

      • 13.8.1 Serum Institute Of India Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Live Attenuated Vaccines Market Size and Growth Rate of Bacterial from 2016 to 2027

    • Figure China Live Attenuated Vaccines Market Size and Growth Rate of Viral from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Live Attenuated Vaccines Market Size and Growth Rate of Hospitals from 2016 to 2027

    • Figure China Live Attenuated Vaccines Market Size and Growth Rate of Clinics from 2016 to 2027

    • Figure China Live Attenuated Vaccines Market Size and Growth Rate of Research Institutes from 2016 to 2027

    • Figure China Live Attenuated Vaccines Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Live Attenuated Vaccines Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Live Attenuated Vaccines

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Live Attenuated Vaccines by Different Types from 2016 to 2027

    • Table Consumption Share of Live Attenuated Vaccines by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Bacterial

    • Figure Market Size and Growth Rate of Viral

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Live Attenuated Vaccines by Different End-Users from 2016 to 2027

    • Table Consumption Share of Live Attenuated Vaccines by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Clinics

    • Figure Market Size and Growth Rate of Research Institutes

    • Figure Market Size and Growth Rate of Others

    • Table China Live Attenuated Vaccines Production by Regions

    • Table China Live Attenuated Vaccines Production Share by Regions

    • Figure China Live Attenuated Vaccines Production Share by Regions in 2016

    • Figure China Live Attenuated Vaccines Production Share by Regions in 2021

    • Figure China Live Attenuated Vaccines Production Share by Regions in 2027

    • Table China Live Attenuated Vaccines Consumption by Regions

    • Table China Live Attenuated Vaccines Consumption Share by Regions

    • Figure China Live Attenuated Vaccines Consumption Share by Regions in 2016

    • Figure China Live Attenuated Vaccines Consumption Share by Regions in 2021

    • Figure China Live Attenuated Vaccines Consumption Share by Regions in 2027

    • Table North China Live Attenuated Vaccines Consumption by Types from 2016 to 2027

    • Table North China Live Attenuated Vaccines Consumption Share by Types from 2016 to 2027

    • Figure North China Live Attenuated Vaccines Consumption Share by Types in 2016

    • Figure North China Live Attenuated Vaccines Consumption Share by Types in 2021

    • Figure North China Live Attenuated Vaccines Consumption Share by Types in 2027

    • Table North China Live Attenuated Vaccines Consumption by End-Users from 2016 to 2027

    • Table North China Live Attenuated Vaccines Consumption Share by End-Users from 2016 to 2027

    • Figure North China Live Attenuated Vaccines Consumption Share by End-Users in 2016

    • Figure North China Live Attenuated Vaccines Consumption Share by End-Users in 2021

    • Figure North China Live Attenuated Vaccines Consumption Share by End-Users in 2027

    • Table Central China Live Attenuated Vaccines Consumption by Types from 2016 to 2027

    • Table Central China Live Attenuated Vaccines Consumption Share by Types from 2016 to 2027

    • Figure Central China Live Attenuated Vaccines Consumption Share by Types in 2016

    • Figure Central China Live Attenuated Vaccines Consumption Share by Types in 2021

    • Figure Central China Live Attenuated Vaccines Consumption Share by Types in 2027

    • Table Central China Live Attenuated Vaccines Consumption by End-Users from 2016 to 2027

    • Table Central China Live Attenuated Vaccines Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Live Attenuated Vaccines Consumption Share by End-Users in 2016

    • Figure Central China Live Attenuated Vaccines Consumption Share by End-Users in 2021

    • Figure Central China Live Attenuated Vaccines Consumption Share by End-Users in 2027

    • Table South China Live Attenuated Vaccines Consumption by Types from 2016 to 2027

    • Table South China Live Attenuated Vaccines Consumption Share by Types from 2016 to 2027

    • Figure South China Live Attenuated Vaccines Consumption Share by Types in 2016

    • Figure South China Live Attenuated Vaccines Consumption Share by Types in 2021

    • Figure South China Live Attenuated Vaccines Consumption Share by Types in 2027

    • Table South China Live Attenuated Vaccines Consumption by End-Users from 2016 to 2027

    • Table South China Live Attenuated Vaccines Consumption Share by End-Users from 2016 to 2027

    • Figure South China Live Attenuated Vaccines Consumption Share by End-Users in 2016

    • Figure South China Live Attenuated Vaccines Consumption Share by End-Users in 2021

    • Figure South China Live Attenuated Vaccines Consumption Share by End-Users in 2027

    • Table East China Live Attenuated Vaccines Consumption by Types from 2016 to 2027

    • Table East China Live Attenuated Vaccines Consumption Share by Types from 2016 to 2027

    • Figure East China Live Attenuated Vaccines Consumption Share by Types in 2016

    • Figure East China Live Attenuated Vaccines Consumption Share by Types in 2021

    • Figure East China Live Attenuated Vaccines Consumption Share by Types in 2027

    • Table East China Live Attenuated Vaccines Consumption by End-Users from 2016 to 2027

    • Table East China Live Attenuated Vaccines Consumption Share by End-Users from 2016 to 2027

    • Figure East China Live Attenuated Vaccines Consumption Share by End-Users in 2016

    • Figure East China Live Attenuated Vaccines Consumption Share by End-Users in 2021

    • Figure East China Live Attenuated Vaccines Consumption Share by End-Users in 2027

    • Table Northeast China Live Attenuated Vaccines Consumption by Types from 2016 to 2027

    • Table Northeast China Live Attenuated Vaccines Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Live Attenuated Vaccines Consumption Share by Types in 2016

    • Figure Northeast China Live Attenuated Vaccines Consumption Share by Types in 2021

    • Figure Northeast China Live Attenuated Vaccines Consumption Share by Types in 2027

    • Table Northeast China Live Attenuated Vaccines Consumption by End-Users from 2016 to 2027

    • Table Northeast China Live Attenuated Vaccines Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Live Attenuated Vaccines Consumption Share by End-Users in 2016

    • Figure Northeast China Live Attenuated Vaccines Consumption Share by End-Users in 2021

    • Figure Northeast China Live Attenuated Vaccines Consumption Share by End-Users in 2027

    • Table Southwest China Live Attenuated Vaccines Consumption by Types from 2016 to 2027

    • Table Southwest China Live Attenuated Vaccines Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Live Attenuated Vaccines Consumption Share by Types in 2016

    • Figure Southwest China Live Attenuated Vaccines Consumption Share by Types in 2021

    • Figure Southwest China Live Attenuated Vaccines Consumption Share by Types in 2027

    • Table Southwest China Live Attenuated Vaccines Consumption by End-Users from 2016 to 2027

    • Table Southwest China Live Attenuated Vaccines Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Live Attenuated Vaccines Consumption Share by End-Users in 2016

    • Figure Southwest China Live Attenuated Vaccines Consumption Share by End-Users in 2021

    • Figure Southwest China Live Attenuated Vaccines Consumption Share by End-Users in 2027

    • Table Northwest China Live Attenuated Vaccines Consumption by Types from 2016 to 2027

    • Table Northwest China Live Attenuated Vaccines Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Live Attenuated Vaccines Consumption Share by Types in 2016

    • Figure Northwest China Live Attenuated Vaccines Consumption Share by Types in 2021

    • Figure Northwest China Live Attenuated Vaccines Consumption Share by Types in 2027

    • Table Northwest China Live Attenuated Vaccines Consumption by End-Users from 2016 to 2027

    • Table Northwest China Live Attenuated Vaccines Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Live Attenuated Vaccines Consumption Share by End-Users in 2016

    • Figure Northwest China Live Attenuated Vaccines Consumption Share by End-Users in 2021

    • Figure Northwest China Live Attenuated Vaccines Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of CSL

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL

    • Figure Sales and Growth Rate Analysis of CSL

    • Figure Revenue and Market Share Analysis of CSL

    • Table Product and Service Introduction of CSL

    • Table Company Profile and Development Status of Astellas Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma

    • Figure Sales and Growth Rate Analysis of Astellas Pharma

    • Figure Revenue and Market Share Analysis of Astellas Pharma

    • Table Product and Service Introduction of Astellas Pharma

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Serum Institute Of India

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Serum Institute Of India

    • Figure Sales and Growth Rate Analysis of Serum Institute Of India

    • Figure Revenue and Market Share Analysis of Serum Institute Of India

    • Table Product and Service Introduction of Serum Institute Of India


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US